Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays.
about
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureTests for finding complex patterns of differential expression in cancers: towards individualized medicineInhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsGene expression in cancer: the application of microarrays.A comparative study of different machine learning methods on microarray gene expression dataCommon human cancer genes discovered by integrated gene-expression analysis.A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomasGene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategyThe miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myelomaCyclin K and cyclin D1b are oncogenic in myeloma cells.Classification of dendritic cell phenotypes from gene expression dataInput of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses.BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase.The molecular classification of multiple myelomaThe therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancerDrug metabolism and clearance system in tumor cells of patients with multiple myelomaHydrogen Sulfide and Cancer.Microarray-based understanding of normal and malignant plasma cells.NY-ESO-1 immunotherapy for multiple myeloma.BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasonep110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancerCystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.Perforin-mediated suppression of B-cell lymphomaKrüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma.Regulation of B-cell entry into the cell cycleExpression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cellsTranscriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.Tyrosine kinase c-Abl regulates the survival of plasma cellsGasotransmitters in cancer: from pathophysiology to experimental therapy.Biological aspects of angiogenesis in multiple myeloma.Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.Asthma-predictive genetic markers in gene expression profiling of peripheral blood mononuclear cells.
P2860
Q24647037-491421D5-F8CA-4F3F-B51C-3ECF8E91083DQ24801330-347478CA-3A21-4EB4-8380-55CE1A82449CQ28487347-FE795E6C-7870-455C-AB7E-FB53D161733FQ30724775-BDB49621-4ACB-49B4-80E9-F8D8A6BE81C1Q31150616-2C81733D-7A80-4F7E-A8C0-B58A1E3A8E2BQ33305350-283C7D2E-B0BF-429D-884E-73D7A3DAA98EQ33314438-C75665D1-5FEA-4F2D-A8C0-E9ABFD14D1D9Q33567153-14649B84-AF97-45A2-A27B-01CD9236E1FEQ33691683-E1EE20E8-2D92-456E-8A8F-E4682AF6C303Q33757020-F8D49AE7-D6C6-4E7C-8002-E5F603045149Q33838260-0F45111C-5B72-47F8-9D67-D27215B24914Q33895292-BBEDC8CD-4ACF-49EE-8EAB-726FC571F886Q34004943-AB1453CF-2073-4B64-AFF9-863DC891B2E0Q34022979-CE9A7946-9A61-44D3-8923-1D6BFC6186C7Q34047859-943D014F-D235-4988-9B0F-A607A3FB905EQ34052565-43CEC294-DFD9-4CFF-B2EC-939DE4FA2472Q34380431-41432A23-BC52-49CD-A093-0EA41456F899Q34388367-3D70D672-A2E7-4F4D-B6B1-82BBDA8EAF17Q34508316-00377B14-758F-49A4-A849-3A5A90E4F558Q34519903-DDAADBE7-A9A9-4508-B2E9-847062D556FAQ34530992-84FCFBDA-49C2-4C33-96EA-C2EA764FBD9EQ35016080-75FE454E-3FDB-4FE5-A6A9-C8B947B9675BQ35742560-E0EC2354-2F43-4455-B6A8-0E843A9F3B45Q36336507-4D098225-72C7-46AE-89EE-1564E48B4A87Q36453354-C1AC582C-77A9-4CE9-8C3E-F82717A1AC4FQ36637651-475B55F0-FC3F-4901-B298-CC7303CFA98BQ36663554-C5DFA991-1169-4B4B-85E7-1AD3FE5F4CCEQ36710895-40EE76E8-5C0D-41AA-A389-853152F8AF96Q37049363-3C4D8D53-5035-4386-A7BA-A2853FA52DAAQ37112901-435679C9-9228-4906-9102-B57CEEB4B436Q37115217-EDEAE0E9-4F87-4D81-8066-DB36D9B7A0D9Q37144899-EC3536D4-BEAA-49B3-B84F-610AE6E21D93Q37256980-5E064D93-1F28-410F-A95E-16D11C0DB72BQ37314430-7B568B4B-DBFD-4D4C-8712-96826910A969Q37316361-A184C771-6BE4-42C9-84FF-9A2BED31B1F4Q37563352-665ED4BE-9743-4E1D-BF01-46E8C3E97C01Q37656625-498E2DBA-B8B2-4839-899F-4D4C69B43EADQ37956524-7F4487D2-B010-463D-8EBB-FE36E918025DQ38101343-936626DC-85C3-435C-AD4A-4AB38AF5B2F8Q38547629-C63E4812-ECF1-44AF-9E54-666D0B5FC4C0
P2860
Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Comparison of gene expression ...... s with oligonucleotide arrays.
@en
type
label
Comparison of gene expression ...... s with oligonucleotide arrays.
@en
prefLabel
Comparison of gene expression ...... s with oligonucleotide arrays.
@en
P2093
P2860
P356
P1433
P1476
Comparison of gene expression ...... s with oligonucleotide arrays.
@en
P2093
Bernard Klein
Florence Pellet
Guilhem Requirand
Jean-François Rossi
John De Vos
Karin Tarte
Matthias Ensslen
Michel Jourdan
Pierre Raynaud
Thierry Rème
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205868
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1023456194